Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use may ...

Tamiflu, the same antiviral used to treat ordinary seasonal influenza, is the front line medication recommended for treating highly pathogenic bird flu (Photo by Rui Vieira/PA Images via Getty Images) ...

The virus that causes COVID-19 might be becoming resistant to antiviral treatments, new research has warned. But should we be concerned? The antiviral drugs nirmatrelvir and remdesivir are recommended ...

Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

ATLANTA — Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

(Reuters) - The U.S. Centers for Disease Control and Prevention said on Thursday its analysis of samples from the first severe case of bird flu in the country last week showed mutations not seen in ...

"It's the biggest experiment that's ever happened." In a stunningly short period of time, the delta variant has changed the course of the COVID-19 pandemic by evolving to become more transmissible ...

A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...

For decades, Arieh Warshel, USC Distinguished Professor of Chemistry and a 2013 Nobel laureate, has used computer simulations to understand how enzymes—fundamental to nearly every biological process ...